Denali Therapeutics Inc. (DNLI) Nonoperating Income (Expense) USD 2017 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Denali Therapeutics Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2017 to 2023.
  • Denali Therapeutics Inc. Nonoperating Income (Expense) for the quarter ending December 31, 2023 was $13.1 M, a 97.1% increase year-over-year.
  • Denali Therapeutics Inc. Nonoperating Income (Expense) for the twelve months ending December 31, 2023 was $51.5 M, a 249% increase year-over-year.
  • Denali Therapeutics Inc. annual Nonoperating Income (Expense) for 2023 was $51.5 M, a 249% increase from 2022.
  • Denali Therapeutics Inc. annual Nonoperating Income (Expense) for 2022 was $14.8 M, a 222% increase from 2021.
  • Denali Therapeutics Inc. annual Nonoperating Income (Expense) for 2021 was $4.6 M, a 50.3% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $51.5 M $13.1 M +$6.47 M +97.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $45 M $14.4 M +$10.3 M +245% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $34.8 M $12.9 M +$10.3 M +387% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $24.5 M $11 M +$9.76 M +763% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $14.8 M $6.66 M +$5.38 M +418% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $9.4 M $4.19 M +$3.18 M +317% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $6.22 M $2.65 M +$1.52 M +135% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $4.69 M $1.28 M +$99 K +8.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $4.6 M $1.29 M -$345 K -21.2% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $4.94 M $1.01 M -$939 K -48.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $5.88 M $1.13 M -$1.47 M -56.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $7.35 M $1.18 M -$1.89 M -61.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $9.24 M $1.63 M -$2.18 M -57.2% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 $11.4 M $1.94 M -$1.84 M -48.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $13.3 M $2.6 M -$1.52 M -36.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $14.8 M $3.07 M -$447 K -12.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $15.2 M $3.81 M +$997 K +35.5% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 $14.2 M $3.78 M +$1.19 M +45.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $13 M $4.11 M +$1.46 M +54.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $11.6 M $3.52 M +$1.45 M +69.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $10.1 M $2.81 M +$2.16 M +330% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-26
Q3 2018 $7.97 M $2.59 M +$2.15 M +484% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $5.83 M $2.66 M +$2.22 M +512% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $3.6 M $2.07 M +$1.65 M +388% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $1.96 M $653 K Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 $444 K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $434 K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $424 K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.